☆ 4.5 Letter

Reduction of serum thymus and activation-regulated chemokine after short-term intensive therapy may predict better prognosis of moderate to severe atopic dermatitis

JOURNAL OF DERMATOLOGY (2019)

Related references

Note: Only part of the references are listed.
Article Dermatology

Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016

Hidehisa Saeki et al.

JOURNAL OF DERMATOLOGY (2016)

Add to Collection
Review Dermatology

Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis

Yoko Kataoka

JOURNAL OF DERMATOLOGY (2014)

Add to Collection
Review Dermatology

Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases

Hidehisa Saeki et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2006)

Add to Collection
Article Allergy

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity

T Kakinuma et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.